S-Tenatoprazole-Na (STU-Na)

DRUG2 trials

Sponsors

STEBA France

Conditions

Duodenal UlcerEsophagitisEsophagitis, RefluxGastroesophageal RefluxStomach Ulcer

Phase 1

Dose-Effect of S-Tenatoprazole-Na(STU-Na) 30 mg, 60 mg, 90 mg and 120 mg in Healthy Volunteers

CompletedNCT00284908

STEBA FranceDuodenal Ulcer, Esophagitis, Gastroesophageal Reflux +1

Start: 2006-09-30End: 2006-11-30Updated: 2008-03-24

Phase 2

Efficiency Study of S-Tenatoprazole-Na to Treat Erosive or Ulcerative Esophagitis

SuspendedNCT00282555

STEBA FranceEsophagitis, Reflux

Start: 2006-02-28Target: 450Updated: 2008-03-19